A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
The global Bio Pharma Buffer market was valued at US$ 784 million in 2020 and is expected to reach US$ 1277 million by the end of 2029, growing at a CAGR of 7.2% during 2021-2029.
This report focuses on Bio Pharma Buffer volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Bio Pharma Buffer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Bio Pharma Buffer Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
1 Bio Pharma Buffer Market Overview
1.1 Product Overview and Scope of Bio Pharma Buffer
1.2 Bio Pharma Buffer Segment by Type
1.2.1 Global Bio Pharma Buffer Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Bio Pharma Buffer Segment by Application
1.3.1 Global Bio Pharma Buffer Sales Comparison by Application: (2021-2029)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Bio Pharma Buffer Market Size Estimates and Forecasts
1.4.1 Global Bio Pharma Buffer Revenue 2016-2029
1.4.2 Global Bio Pharma Buffer Sales 2016-2029
1.4.3 Bio Pharma Buffer Market Size by Region: 2016 Versus 2021 Versus 2029
2 Bio Pharma Buffer Market Competition by Manufacturers
2.1 Global Bio Pharma Buffer Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bio Pharma Buffer Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bio Pharma Buffer Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bio Pharma Buffer Manufacturing Sites, Area Served, Product Type
2.5 Bio Pharma Buffer Market Competitive Situation and Trends
2.5.1 Bio Pharma Buffer Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bio Pharma Buffer Players Market Share by Revenue
2.5.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bio Pharma Buffer Retrospective Market Scenario by Region
3.1 Global Bio Pharma Buffer Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Bio Pharma Buffer Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Bio Pharma Buffer Market Facts & Figures by Country
3.3.1 North America Bio Pharma Buffer Sales by Country
3.3.2 North America Bio Pharma Buffer Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bio Pharma Buffer Market Facts & Figures by Country
3.4.1 Europe Bio Pharma Buffer Sales by Country
3.4.2 Europe Bio Pharma Buffer Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Region
3.5.1 Asia Pacific Bio Pharma Buffer Sales by Region
3.5.2 Asia Pacific Bio Pharma Buffer Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bio Pharma Buffer Market Facts & Figures by Country
3.6.1 Latin America Bio Pharma Buffer Sales by Country
3.6.2 Latin America Bio Pharma Buffer Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country
3.7.1 Middle East and Africa Bio Pharma Buffer Sales by Country
3.7.2 Middle East and Africa Bio Pharma Buffer Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Bio Pharma Buffer Historic Market Analysis by Type
4.1 Global Bio Pharma Buffer Sales Market Share by Type (2016-2021)
4.2 Global Bio Pharma Buffer Revenue Market Share by Type (2016-2021)
4.3 Global Bio Pharma Buffer Price by Type (2016-2021)
5 Global Bio Pharma Buffer Historic Market Analysis by Application
5.1 Global Bio Pharma Buffer Sales Market Share by Application (2016-2021)
5.2 Global Bio Pharma Buffer Revenue Market Share by Application (2016-2021)
5.3 Global Bio Pharma Buffer Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Avantor
6.1.1 Avantor Corporation Information
6.1.2 Avantor Description and Business Overview
6.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Avantor Bio Pharma Buffer Product Portfolio
6.1.5 Avantor Recent Developments/Updates
6.2 Alfa Aesar (Thermo Fisher)
6.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
6.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
6.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolio
6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Bio Pharma Buffer Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Corporation Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lonza Bio Pharma Buffer Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bio-Rad Bio Pharma Buffer Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BD Bio Pharma Buffer Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GE Healthcare Bio Pharma Buffer Product Portfolio
6.7.5 GE Healthcare Recent Developments/Updates
6.8 Promega Corporation
6.8.1 Promega Corporation Corporation Information
6.8.2 Promega Corporation Description and Business Overview
6.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Promega Corporation Bio Pharma Buffer Product Portfolio
6.8.5 Promega Corporation Recent Developments/Updates
6.9 Hamilton Company
6.9.1 Hamilton Company Corporation Information
6.9.2 Hamilton Company Description and Business Overview
6.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hamilton Company Bio Pharma Buffer Product Portfolio
6.9.5 Hamilton Company Recent Developments/Updates
6.10 XZL BIO-TECHNOLOGY
6.10.1 XZL BIO-TECHNOLOGY Corporation Information
6.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
6.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolio
6.10.5 XZL BIO-TECHNOLOGY Recent Developments/Updates
6.11 SRL
6.11.1 SRL Corporation Information
6.11.2 SRL Bio Pharma Buffer Description and Business Overview
6.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
6.11.4 SRL Bio Pharma Buffer Product Portfolio
6.11.5 SRL Recent Developments/Updates
7 Bio Pharma Buffer Manufacturing Cost Analysis
7.1 Bio Pharma Buffer Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bio Pharma Buffer
7.4 Bio Pharma Buffer Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bio Pharma Buffer Distributors List
8.3 Bio Pharma Buffer Customers
9 Bio Pharma Buffer Market Dynamics
9.1 Bio Pharma Buffer Industry Trends
9.2 Bio Pharma Buffer Growth Drivers
9.3 Bio Pharma Buffer Market Challenges
9.4 Bio Pharma Buffer Market Restraints
10 Global Market Forecast
10.1 Bio Pharma Buffer Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bio Pharma Buffer by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Bio Pharma Buffer by Type (2022-2029)
10.2 Bio Pharma Buffer Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bio Pharma Buffer by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Bio Pharma Buffer by Application (2022-2029)
10.3 Bio Pharma Buffer Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bio Pharma Buffer by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Bio Pharma Buffer by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Bio Pharma Buffer Sales (K Liter) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Bio Pharma Buffer Sales (K Liter) Comparison by Application (2021-2029)
Table 3. Global Bio Pharma Buffer Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Bio Pharma Buffer Covered in This Study
Table 5. Global Bio Pharma Buffer Sales (K Liter) of Key Manufacturers (2016-2021)
Table 6. Global Bio Pharma Buffer Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Bio Pharma Buffer Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Bio Pharma Buffer Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Bio Pharma Buffer Average Price (USD/Liter) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Bio Pharma Buffer Manufacturing Sites and Area Served
Table 11. Manufacturers Bio Pharma Buffer Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 16. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Table 17. Global Bio Pharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 19. North America Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 20. North America Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 22. Europe Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 23. Europe Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 24. Europe Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 27. Asia Pacific Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Bio Pharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
Table 30. Latin America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 31. Latin America Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 32. Latin America Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 35. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 38. Global Bio Pharma Buffer Sales (K Liter) by Type (2016-2021)
Table 39. Global Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 40. Global Bio Pharma Buffer Revenue (Million US$) by Type (2016-2021)
Table 41. Global Bio Pharma Buffer Revenue Share by Type (2016-2021)
Table 42. Global Bio Pharma Buffer Price (USD/Liter) by Type (2016-2021)
Table 43. Global Bio Pharma Buffer Sales (K Liter) by Application (2016-2021)
Table 44. Global Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 45. Global Bio Pharma Buffer Revenue (Million US$) by Application (2016-2021)
Table 46. Global Bio Pharma Buffer Revenue Share by Application (2016-2021)
Table 47. Global Bio Pharma Buffer Price (USD/Liter) by Application (2016-2021)
Table 48. Avantor Corporation Information
Table 49. Avantor Description and Business Overview
Table 50. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 51. Avantor Bio Pharma Buffer Product
Table 52. Avantor Recent Developments/Updates
Table 53. Alfa Aesar (Thermo Fisher) Corporation Information
Table 54. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 55. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 56. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
Table 57. Alfa Aesar (Thermo Fisher) Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 61. Merck Bio Pharma Buffer Product
Table 62. Merck Recent Developments/Updates
Table 63. Lonza Corporation Information
Table 64. Lonza Description and Business Overview
Table 65. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 66. Lonza Bio Pharma Buffer Product
Table 67. Lonza Recent Developments/Updates
Table 68. Bio-Rad Corporation Information
Table 69. Bio-Rad Description and Business Overview
Table 70. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 71. Bio-Rad Bio Pharma Buffer Product
Table 72. Bio-Rad Recent Developments/Updates
Table 73. BD Corporation Information
Table 74. BD Description and Business Overview
Table 75. BD Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 76. BD Bio Pharma Buffer Product
Table 77. BD Recent Developments/Updates
Table 78. GE Healthcare Corporation Information
Table 79. GE Healthcare Description and Business Overview
Table 80. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 81. GE Healthcare Bio Pharma Buffer Product
Table 82. GE Healthcare Recent Developments/Updates
Table 83. Promega Corporation Corporation Information
Table 84. Promega Corporation Description and Business Overview
Table 85. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 86. Promega Corporation Bio Pharma Buffer Product
Table 87. Promega Corporation Recent Developments/Updates
Table 88. Hamilton Company Corporation Information
Table 89. Hamilton Company Description and Business Overview
Table 90. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 91. Hamilton Company Bio Pharma Buffer Product
Table 92. Hamilton Company Recent Developments/Updates
Table 93. XZL BIO-TECHNOLOGY Corporation Information
Table 94. XZL BIO-TECHNOLOGY Description and Business Overview
Table 95. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 96. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
Table 97. XZL BIO-TECHNOLOGY Recent Developments/Updates
Table 98. SRL Corporation Information
Table 99. SRL Description and Business Overview
Table 100. SRL Bio Pharma Buffer Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2016-2021)
Table 101. SRL Bio Pharma Buffer Product
Table 102. SRL Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Bio Pharma Buffer Distributors List
Table 106. Bio Pharma Buffer Customers List
Table 107. Bio Pharma Buffer Market Trends
Table 108. Bio Pharma Buffer Growth Drivers
Table 109. Bio Pharma Buffer Market Challenges
Table 110. Bio Pharma Buffer Market Restraints
Table 111. Global Bio Pharma Buffer Sales Forecast by Type (2022-2029) & (K Liter)
Table 112. Global Bio Pharma Buffer Sales Market Share Forecast by Type (2022-2029)
Table 113. Global Bio Pharma Buffer Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 114. Global Bio Pharma Buffer Revenue Market Share Forecast by Type (2022-2029)
Table 115. Global Bio Pharma Buffer Sales Forecast by Application (2022-2029) & (K Liter)
Table 116. Global Bio Pharma Buffer Sales Market Share Forecast by Application (2022-2029)
Table 117. Global Bio Pharma Buffer Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 118. Global Bio Pharma Buffer Revenue Market Share Forecast by Application (2022-2029)
Table 119. Global Bio Pharma Buffer Sales Forecast by Region (2022-2029) & (K Liter)
Table 120. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2022-2029)
Table 121. Global Bio Pharma Buffer Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 122. Global Bio Pharma Buffer Revenue Market Share Forecast by Region (2022-2029)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bio Pharma Buffer
Figure 2. Global Bio Pharma Buffer Market Share by Type in 2020 & 2029
Figure 3. Phosphates Type Product Picture
Figure 4. Acetates Type Product Picture
Figure 5. TRIS Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bio Pharma Buffer Market Share by Application in 2020 & 2029
Figure 8. Research Institution
Figure 9. Pharmaceutical Industry
Figure 10. Others
Figure 11. Global Bio Pharma Buffer Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Bio Pharma Buffer Market Size 2016-2029 (US$ Million)
Figure 13. Global Bio Pharma Buffer Sales 2016-2029 (K Liter)
Figure 14. Global Bio Pharma Buffer Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Bio Pharma Buffer Sales Share by Manufacturers in 2020
Figure 16. Global Bio Pharma Buffer Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Bio Pharma Buffer Players: Market Share by Revenue in 2020
Figure 18. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Figure 20. Global Bio Pharma Buffer Sales Market Share by Region in 2020
Figure 21. Global Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
Figure 22. Global Bio Pharma Buffer Revenue Market Share by Region in 2020
Figure 23. U.S. Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Bio Pharma Buffer by Type (2016-2021)
Figure 48. Sales Market Share of Bio Pharma Buffer by Application (2016-2021)
Figure 49. Sales Market Share of Bio Pharma Buffer by Application in 2020
Figure 50. Revenue Share of Bio Pharma Buffer by Application (2016-2021)
Figure 51. Revenue Share of Bio Pharma Buffer by Application in 2020
Figure 52. Manufacturing Cost Structure of Bio Pharma Buffer
Figure 53. Manufacturing Process Analysis of Bio Pharma Buffer
Figure 54. Bio Pharma Buffer Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
